As Opioid Use Climbs, Neonatal Abstinence Syndrome Rises in New Hampshire by Smith, Kristin
As Opioid Use Climbs, Neonatal Abstinence 
Syndrome Rises in New Hampshire
K r i s t i n  S m i t h







The opioid crisis besetting every region of the United 
States directly affects more than just those who use 
substances. For a pregnant woman, a consequence of 
substance use can be neonatal abstinence syndrome 
(NAS)—withdrawal symptoms experienced by the 
newborn (see Box 1). 
NAS is on the rise in New Hampshire, but prenatal 
care for the mother can reduce or eliminate the risk. 
Newborns who are treated recover, yet mothers using 
opioids are often using other substances and confront-
ing behavioral health issues which complicate recovery. 
This brief analyzes inpatient hospital discharge 
data (2012–2015) to assess the prevalence of NAS in 
New Hampshire; describes one hospital’s successful 
program for treating pregnant women and newborns; 
discusses how comprehensive and coordinated care 
and home visiting services provided through com-
munity based organizations can support new mothers 
and families; and discusses how a recent change to 
New Hampshire law intended to support child  
protection may be having unintended consequences. 
Opioid Drug Use and NAS  
in New Hampshire
Drug overdose deaths are on the rise in New Hampshire. 
In 2016, the state medical examiner reported 488 deaths 
from drug overdoses, up from 192 just four years 
earlier (Figure 1).1 Overdose deaths among women 
nearly tripled between 2008 and 2016, from 52 to 149. 
However, because the incidence of drug overdose death 
among men grew at a faster pace, women represented 
a smaller proportion of overdose deaths in 2016 (31 
percent) than in 2008 (44 percent).2
Opioid-related emergency department visits can be 
used to estimate opioid use. In 2016, there were 2,632 
female and 3,452 male visits,3 and they were most 
prevalent among 20–29-year-olds and 30–39-year-olds, 
the typical child-bearing years for women. 
An increase in maternal drug use accounts for a 
rise in the number of newborns diagnosed with NAS. 
The rate of NAS in the United States rose from 1.2 per 
every 1,000 hospital births in 2000 to 5.8 per 1,000 
in 2012,4 leading many to call perinatal opioid use a 
national public health crisis.5 In New Hampshire, NAS 
has increased fivefold since the early 2000s (Figure 2). 
In 2015, 269 infants were diagnosed with NAS, com-
pared to 52 in 2005.6 This number may be an underes-
timate, because hospitals may report NAS differently 
depending on provider documentation and coding 
of diagnosis, and also issues of data quality.7 Figure 2 
also shows that the rate of NAS births per 1,000 live 
hospital births reached 24.4 per 1,000 in 2015. In other 
words, at least 2.4 percent of live New Hampshire 
births in 2015 were diagnosed with NAS. 
In 2015, New Hampshire newborns diagnosed with 
NAS remained in the hospital on average twelve days, 
owing to some needing monitoring and care while 
they were weaned off opiates, compared to three days 
for newborns not born exposed. However, not all 
newborns with NAS needed intensive services, and 41 
percent were able to leave the hospital within five days. 
FIGURE 1. NUMBER OF DEATHS FROM DRUG OVERDOSES IN NEW HAMPSHIRE, 
BY SEX, 1995–2016
Early Successes in 
Addressing NAS 
Hospitals are responding to the 
increased prevalence of NAS in 
different ways. Some offer prenatal 
comprehensive and coordinated care, 
including medication-assisted treat-
ment, while others have instituted 
postnatal infant cuddling programs, 
since skin-to-skin contact is impor-
tant for infants during withdrawal 
and recovery. Since 2015 (the time 
of data collection), several New 
Hampshire hospitals have instituted 
protocols for NAS intervention that 
have shortened the length of stay for 
newborns with NAS. 
The Dartmouth-Hitchcock Medical 
Center (DHMC) launched one of the 
first programs in New Hampshire, 
the Moms in Recovery program, in 
2013 to address the need for access to 
treatment among pregnant women 
who were using opiates. Moms in 
Recovery uses an integrated model 
to provide outpatient medication-
assisted treatment, maternity care, 
maternal behavioral health care, 
referrals to community services, and 
case management. Participants attend 
group treatment sessions focused 
on addiction treatment and educa-
tion and receive individual visits for 
medication, individual therapy, case 
management, and prenatal care. 
DHMC reports that its program 
has been successful in achieving 
positive maternal and neonatal 
outcomes, and in some cases the 
birth outcomes are comparable to 
the overall population of births. For 
example, fewer than 25 percent of 
infants born to DHMC Moms in 
Recovery participants require treat-
ment for NAS; the length of stay for 
neonates requiring treatment has 
declined by three days since 2013, 
and about 80 percent of program 
participants initiate breastfeeding.8
In 2015, 7.8 percent of newborns 
to New Hampshire residents at 
DHMC were diagnosed with NAS,  
a higher proportion than the state-
wide average of 2.4 percent,9 but 
NAS births at DHMC had a shorter 
length of stay compared with other 
New Hampshire hospitals—8.3 
versus 13.3 days.10 Although not 
conclusive, these data suggest that 
DHMC’s programs are reducing 
the length of the hospital stay for 
newborns with NAS. 
NAS births are more costly on 
average than other births, likely 
owing to longer hospital stays.11  
In 2015, the total discharge amount 
for all births coded with an NAS 
diagnosis in New Hampshire aver-
aged $33,700, compared to $7,800 
for those not diagnosed with NAS.12 
Medicaid covered 78 percent of 
NAS births in 2013.13 
Source: Office of the Chief Medical Examiner, Department of Justice. Number of deaths for men and women do 
not add to total due to missing data by sex. 
FIGURE 2. NEONATAL ABSTINENCE SYNDROME AMONG NEW HAMPSHIRE 
INFANT DISCHARGES, 2000–2015
Source: New Hampshire inpatient hospital discharge data, 2000–2015. 2000–2011 data published in Maternal 
and Child Health, “Neonatal Abstinence Syndrome” (Concord: New Hampshire Department of Health and Human 
Services); 2012–2015 data analyzed by the author. The 2000–2011 data include infant discharges from both 
in-state and out-of-state hospitals among New Hampshire residents. Due to data constraints, the 2012–2015 
data include discharges from only in-state hospitals among New Hampshire residents.
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and Families. A small portion of the 
CFSS home visiting program is paid 
for by Medicaid.
MIECHV uses the Healthy 
Families America model, a research-
based voluntary home visiting 
program that targets families most 
at risk of child maltreatment and 
adverse childhood experiences. 
Many of the families receiving 
MIECHV services struggle with 
substances: an evaluation of New 
Hampshire’s Healthy Families 
America found that 37 percent 
of caregivers served by the pro-
gram were assessed as “known or 
suspected of substance misuse.”22 
Families voluntarily enroll in ser-
vices prenatally or within two weeks 
after a child’s birth, and services 
span up to the child’s third birthday 
with the goal of promoting healthy 
child development and preventing 
child abuse and neglect. In 2016, 
MIECHV served 325 families at 
11 sites, for a total of 4,639 home 
visits.23 It is important to note that 
in October 2017 Congress let the 
MIECHV program expire.
Families with a child under 21 
are eligible to participate in CFSS 
voluntary services, which include 
home visiting and other programs 
offered by community-based 
nonprofit service organizations. 
Families voluntarily request ser-
vices, and a service plan is initiated. 
In 2015, 1,048 New Hampshire 
families participated in CFSS, with 
3,430 family members served, 
including 1,926 children.24
For those who are eligible, CFSS 
voluntary home visiting services can 
be charged to the Medicaid home 
visiting program, Home Visiting New 
Hampshire, which has strict eligibility 
guidelines. All mothers with infants 
diagnosed with NAS are eligible, as 
Box 1: What Is NAS? 
Neonatal abstinence syndrome is a set of conditions occurring when a 
newborn experiences withdrawal symptoms after birth from drug expo-
sure before birth. It is most often caused by opioids.16 Symptoms appear 
shortly after birth and include irritability, problems feeding, watery stools, 
overly toned muscles, tremors, seizures, and/or breathing problems.17 
Data from prenatal care and treatment programs show that birth out-
comes are better when pregnant women who are using drugs participate 
in prenatal care and undergo substance use treatment. Negative birth 
outcomes such as neonatal withdrawal, prematurity, fetal demise, and 
low birth weight are reduced when medication-assisted treatment, such 
as administration of methadone or buprenorphine, is prescribed during 
pregnancy.18 NAS can be treated or managed in the hospital after birth, 
and infants who are treated recover. The long-term effects of prenatal 
exposure are difficult to determine because of the challenge of isolating 
the independent effect of prenatal opiate exposure, prenatal co-exposure 
to other substances (tobacco, alcohol, other illicit drugs), and behavioral 
health and environmental factors (mental health, poverty, poor prenatal 
care).19 While the research is inconsistent as to the long-term conse-
quences of NAS, studies consistently show that children diagnosed with 
fetal alcohol syndrome demonstrate delays in motor functions, poor 
coordination, delays in fine motor skills, and cognitive disability that 
persists into childhood.20
Increase and Target 
Services to Address NAS 
Statewide
During pregnancy, women who are 
drug dependent often voice motiva-
tion to stop using drugs and to seek 
treatment.14 Thus, pregnancy pro-
vides an opportune time for health 
care providers and hospitals to initi-
ate services and provide referrals, 
and there are a variety of options. 
Community-based nonprofit ser-
vice organizations15 are at the front 
line of the opioid crisis, providing 
services on a voluntary basis to 
families in need. Services support 
and promote family health and 
well-being through education and 
prevention, often in collaboration 
with other social service agencies 
and local public and private organi-
zations. Programs offered typically 
include health education, safety, 
and injury prevention; assistance 
with enrollment in health insurance, 
nutrition programs, or child care 
payment assistance programs; fam-
ily mentoring, parenting, and child 
development education; domestic 
violence prevention and interven-
tions services; and home visiting. 
Home visiting has been shown to 
improve maternal and infant health, 
increase children’s school readi-
ness and safety, and improve family 
self-sufficiency.21 Two state-wide 
programs operate on a contract 
basis through community-based 
nonprofit service organizations: 
the Maternal Infant and Early 
Childhood Home Visiting Program 
(MIECHV), which is under the 
Maternal and Child Health Section 
of the New Hampshire Department 
of Health and Human Services; 
and Comprehensive Family 
Support Services (CFSS), under the 
Department of Children, Youth, 
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long as they are Medicaid recipients, 
first-time mothers, and under the 
age of 21 enrolling in the program 
no more than two weeks after the 
child’s birth. Services can be provided 
up to the child’s first birthday. Many 
families are likely not aware of these 
services because hospitals typically 
give referrals for outside services at 
discharge, and providers may shy 
away from referrals for services that 
are associated with the Department 
of Children, Youth, and Families. 
Moreover, Medicaid’s strict home-
visiting guidelines translate into 
few families being eligible for and 
enrolling in the program. Loosening 
the age restriction, allowing home 
visits at the time of any birth, and 
lengthening the signup period would 
expand access to more families.
Working with hospitals, maternal 
health care providers, and pediatri-
cians to encourage referrals to home 
visiting for newborns diagnosed with 
NAS and their families could be an 
important first step in ensuring con-
tinued child health. Offering pre- and 
postnatal home visits to all families 
could reduce stigma and go a long 
way toward helping all new parents in 
the first days home with a new baby. 
Challenges to Addressing 
NAS Statewide
Pregnant women are reluctant to 
disclose their opioid use because 
of the stigma associated with using 
substances, especially while preg-
nant, and because of the fear that a 
provider will report their substance 
use to Child Protective Services, 
resulting in their child being taken 
away and their parental rights ter-
minated.25 Yet mothers who do not 
disclose suffer in silence and do not 
get the care and services they need, 
and their newborns have longer, 
harder recoveries in the hospital. 
In order to address NAS, legislators, 
advocates, and health care providers 
are calling for a shift away from puni-
tive attitudes toward treatment in an 
effort to reduce shame and encour-
age compliance among pregnant 
women. A successful approach to this 
problem will be one that treats both 
the mother and the newborn with 
comprehensive and coordinated care, 
provides home visiting and other ser-
vices to build confidence in parenting 
and to spot issues before they spiral 
into problems, and has a supportive 
peer and community network. Yet, 
New Hampshire also needs to ensure 
that children are protected from 
harm. Parental drug use endangers 
children’s health and safety in the 
short and long term. Children who 
face adverse childhood experiences 
such as parental addiction and drug 
use have an elevated risk of using 
drugs at age 14 and of continuing that 
use into adulthood.26 
Unintended Consequences 
of Policy Change
In an effort to give the Department of 
Children, Youth, and Families discre-
tion and a legal basis for intervention 
before harm occurs, in June 2016 
New Hampshire amended its Child 
Protection Act to create “a rebuttable 
presumption that the child’s health 
has suffered or is very likely to suffer 
serious impairment” from a parent’s 
drug use and so shifts the responsibil-
ity to parents to provide evidence of 
their compliance with drug use treat-
ment.27 A pregnant woman could use 
participation in medication-assisted 
treatment as evidence of compliance. 
The bill does not conclude that a par-
ent is neglectful if abusing drugs, nor 
does it require departmental involve-
ment or mandate removal of a child. 
The stated intent is to give the depart-
ment discretion and to encourage 
treatment as a way to promote the 
unity of the family when possible.28
However, there is persuasive anec-
dotal evidence of a misunderstand-
ing of the intent of the law by parents 
and within the health care, social ser-
vice, and court systems. This confu-
sion surrounds the interpretation of 
mandatory reporting of child neglect 
to the Department of Children, 
Youth, and Families. Unintended 
consequences may include a chilling 
effect on women seeking prenatal 
care, their willingness to disclose 
during pregnancy, and reporting 
by providers. Any of these conse-
quences are detrimental to newborns 
if pregnant women do not get the 
treatment and care they need. More 
research is needed to determine 
how the law has been interpreted by 
parents and professionals and, in the 
wake of those findings, identify steps 
to clarify any misinterpretation. 
Conclusions
In 2015, 2.4 percent of New 
Hampshire births were diagnosed 
with NAS, and that number is pro-
jected to rise, with implications for 
early intervention programs, early 
education programs, and primary 
schools. Children born drug-exposed 
are at increased risk for behavioral 
health problems, especially if their 
parents continue using. Pregnancy 
is a time to reach out to mothers, as 
they are more receptive to services 
and making a change. Reaching out 
when their children are young to initi-
ate treatment, provide services, and 
shore up community supports within 
a coordinated care and case manage-
ment framework can be in the best 
interest of the child’s health and safety. 
Yet, mothers using opioids are often 
also using other substances, includ-
ing alcohol, cigarettes, marijuana, 
and other illicit drugs, and are often 
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confronting issues related to mental 
health, poverty, homelessness, and/
or domestic violence—all of which 
complicate recovery. Policies and 
programs should not consider opioid 
addiction in isolation, but rather as 
one interconnected symptom within 
a larger context. Both alcohol and 
tobacco use during pregnancy have 
proven negative health consequences 
for children, and the adverse effects 
on children are magnified when com-
bined with opiates. Getting mothers 
on a path to recovery is a formidable 
challenge facing our state, but one 
that ultimately will help children and 
promote family unity.
Data
All hospitals licensed by the New 
Hampshire Department of Health 
and Human Services (DHHS) are 
required by law to report patient-
level discharge information to DHSS. 
Information collected includes, but 
is not limited to, hospital, patient 
demographic characteristics, admis-
sion type, admitting diagnosis, 
procedure codes, length of stay, pri-
mary payer, and total discharge cost 
received from the thirty-two report-
ing hospitals. The 2000–2011 data 
come from the DHHS Maternal and 
Child Health publication, “Neonatal 
Abstinence Syndrome,” and include 
infant discharges from both in-state 
and out-of-state hospitals among 
New Hampshire residents. Due to 
data constraints, the 2012–2015 
data include discharges among 
only in-state hospitals among New 
Hampshire residents. For consistency 
in the trend line, we use the meth-
odology employed by Maternal and 
Child Health (2015) and Patrick et 
al. (2015), which includes all infants 
under 1 coded with a NAS diagnosis 
in the discharge data.  For compari-
sons across hospitals, we include new-
borns coded with a NAS diagnosis in 
the discharge data.
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